Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2006

View Archived Issues

Recent GE patent discloses novel diagnostic agents

Novel therapeutic agents for nephrotoxicity developed at Hiroshima University

Recent patents describe novel therapeutic agents for psychosis, depression, sleep disorders, etc.

New antiviral agents disclosed in recent patent literature

Suven Life Sciences and Lilly to identify GPCR modulators for CNS disorders

Sankyo and Ajinomoto sign license agreement for diabetes compound AJD-101

Sanofi-aventis extends research collaboration with ImmunoGen

Exelixis submits IND for XL-228

Dyax receives FDA guidance on BLA pathway for DX-88

International Trade Commission rules in Roche's favor for Mircera

Ark files response to EMEA for Cerepro

Aktiv-Dry awarded grant to develop inhalable nicotine vaccine

ACE-393 vaccine against C. jejuni begins phase I

ADX-10059 begins phase II program

Pluristem awarded Israeli grant for stem cell product PLX-1

Preliminary results from phase I study of RAV-12 in adenocarcinomas

Tecadenoson protective against myocardial stunning

Cardioprotective effects of eNOS enhancement

Positive phase II data reported for NV1FGF in critical limb ischemia

Promising efficacy for a novel ragweed immunotherapy vaccine

Preliminary evidence for bronchodilating activity of TPI-1020

Evaluation of ACZ-885 in healthy subjects and mild asthmatics

GSK reports on new LRH-1 agonist for therapeutic assessment in cardiovascular disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...